Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...
Thomson Reuters Stock Report - Mesoblast Ltd (MSB-AU)
StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...
Mesoblast Limited - Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect in Patients with Advanced Heart Failure
Wright Investors Service Comprehensive Report for Mesoblast Ltd
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...
Mesoblast Limited - Appendix 4G - Key to Disclosures Corporate Governance Council Principles and Recommendations
Mesoblast Limited - Annual Report 2015
Mesoblast Limited - Notice of Annual General Meeting and Explanatory Memorandum
Mesoblast Limited - Full Product Approval in Japan Received by Mesoblast Licensee
Mesoblast Limited - Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement
Mesoblast Limited - Mesoblast Partner JCR Pharmaceuticals Receives Recommendation for Approval of Mesenchymal Stem Cell Product in Japan